LONDON--(BUSINESS WIRE)-- A hospital acquired infection (HAI), also known as a 'nosocomial' infection, is an infection acquired during hospital care which was not present or incubating at the time of admission. Infections which occur more than 48 hours after admission are also considered nosocomial.
Both diagnostics and treatment segments taken together are valued at more than $9 billion for 2010 with 2015 sales expected to reach $10.3 billion. The market has grown by 3% year-on-year, with sales increasing from $7.9 billion in 2005. With the treatment segment struggling to maintain growth, the testing segment is likely to offset declines starting in 2012.
New market research report “Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends” worked out by Kalorama Information focuses mainly on bacterial nosocomial infections with some mention of viral infections. The study features valuable data and information including total size and growth of the market, key issues and trends impacting the sector, provides comparison of molecular testing with conventional testing, offers detailed company profiles and future market forecasts to 2015. The market analysis considers primarily the epidemiological considerations and the size of patient groups both in the United States and globally, where available.
Report Details:
Published: July, 2011
Pages: 150
Price: US$ 3,995.00
Report Contents:
CHAPTER ONE: EXECUTIVE SUMMARY
Overview
Infection Control Summary
Scope and Methodology
Total Size and Growth of the Market
Issues and Trends Affecting Market
Molecular Testing vs. Conventional Testing
Leading Competitors
CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
Overview
Introduction to Pathogens
Classification of Antibacterial Organisms
Common Hospital (nosocomial) Infections
Description of Infections
Acinetobacter Baumannii
Clostridium Difficile
Gastroenteritis
Hospital-Acquired Pneumonia (HAP)
Pseudomonas Aeruginosa
Staphylococcus Aureus/Methicillin-Resistant Staphylococcus Aureus
Stenotrophomonas Maltophilia
Tuberculosis
Urinary Tract Infections
Vancomycin-Resistant Enterococcus
Hospital Units and Infection Risks
Burn Units
Intensive Care Units
Emergency Departments
Principles of Anti-bacterial Therapy
Infecting Organism
Antibiotic Sensitivity Testing
Site of Infection
Host Defenses and Organ Function
Antibiotic Pharmacokinetics
Monitoring Therapy
General Infection Statistics
Nosocomial Infection Statistics
Populations at Risk for Infection
Demographics of the World
Infections and Drug Resistance
Causes of Drug Resistance
Antibiotic Abuse
…
To order the report or ask for free sample pages, please contact [email protected]
CONTACT:
The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
www.marketpublishers.com
KEYWORDS: United Kingdom Europe
INDUSTRY KEYWORDS: Health Hospitals Communications Marketing General Health
MEDIA:
Logo |